Japan Lifeline (7575) · InitiativeRestated
Discontinuation of Thoracic Stent Graft Sales
First written in FY2020-Q2. 1 of 2 entries say "Restated". Latest entry: FY2020-Q3.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Decline in Direct Sales Due to the Discontinuation of Surgical ProductsA theme 2 companies write about · 2 as a headwind · 0 as a tailwind
0 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2020-Q3RestatedAnnual report
「Sales of stent grafts used in the percutaneous treatment of aortic disease declined year on year because we discontinued handling thoracic products in March 2019.」
The discontinuation of thoracic stent graft sales in March 2019 and its negative impact on surgery-related sales were reconfirmed. - FY2020-Q2First statedAnnual report
「Sales of stent grafts, medical devices used in percutaneous treatment of aortic disease, declined year on year because we discontinued handling thoracic products in March 2019.」
The discontinuation of thoracic stent graft sales in March 2019 and its negative impact on surgery-related sales were recorded as a separate theme for the first time.